KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Amortization - Intangibles (2017 - 2025)

Sarepta Therapeutics (SRPT) has 9 years of Amortization - Intangibles data on record, last reported at $601000.0 in Q4 2024.

  • For Q4 2024, Amortization - Intangibles fell 21.23% year-over-year to $601000.0; the TTM value through Dec 2024 reached $2.4 million, up 54.27%, while the annual FY2024 figure was $2.4 million, 54.27% up from the prior year.
  • Amortization - Intangibles reached $601000.0 in Q4 2024 per SRPT's latest filing, roughly flat from $602000.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $763000.0 in Q4 2023 and bottomed at $165000.0 in Q2 2020.
  • Average Amortization - Intangibles over 5 years is $304200.0, with a median of $179000.0 recorded in 2021.
  • Peak YoY movement for Amortization - Intangibles: fell 23.96% in 2020, then soared 326.26% in 2023.
  • A 5-year view of Amortization - Intangibles shows it stood at $203000.0 in 2020, then dropped by 11.82% to $179000.0 in 2021, then changed by 0.0% to $179000.0 in 2022, then surged by 326.26% to $763000.0 in 2023, then dropped by 21.23% to $601000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Amortization - Intangibles were $601000.0 in Q4 2024, $602000.0 in Q3 2024, and $601000.0 in Q2 2024.